Citation

Shuster J. Hosp. Pharm. 2007; 42(11): 988-994.

Copyright

(Copyright © 2007, Thomas Land Publishers)

DOI

10.1310/hpj4211-988

PMID

unavailable

Abstract

full title: Cerebral ischemia related to isotretinoin; Venlafaxine-induced alopecia; Cognitive dysfunction with tolterodine; Retinal artery occlusion after injection of long-acting risperidone; Olanzapine-induced chylomicronemia presenting as pancreatitis; Metabolic effects of the atypical antipsychotics - An editorial; Another drug-induced pancreatitis - This one caused by a tyrosine kinase inhibitor; Suicide attempts related to antidepressant medications.

Language: en

Keywords

human; abdominal pain; depression; schizophrenia; suicide attempt; acne; isotretinoin; review; pancreatitis; mental disease; antidepressant agent; hospital admission; amfebutamone; citalopram; cognitive defect; mirtazapine; serotonin uptake inhibitor; venlafaxine; hallucination; quetiapine; nuclear magnetic resonance imaging; acetylsalicylic acid; diazepam; trazodone; olanzapine; risperidone; drug withdrawal; computer assisted tomography; simvastatin; drug information; hypertension; atypical antipsychotic agent; amnesia; alopecia; insulin; atenolol; drug dose regimen; central nervous system disease; heparin; drug dose reduction; brain ischemia; muscarinic receptor blocking agent; aphasia; dysarthria; hypertriglyceridemia; hydration; drug dose increase; drug substitution; hypesthesia; blurred vision; oxybutynin; drug delivery system; overactive bladder; tolterodine; facial nerve paralysis; sorafenib; dipyridamole; occlusive cerebrovascular disease; gluconate zinc; protein tyrosine kinase inhibitor; retina artery occlusion